

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 6.81593515 |
| 2 | central nervous system myelination (GO:0022010) | 6.81593515 |
| 3 | nucleobase catabolic process (GO:0046113) | 5.06764859 |
| 4 | synaptic vesicle maturation (GO:0016188) | 4.88788928 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 4.79233577 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.50143042 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.44634904 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.41380578 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.40565755 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 4.40046947 |
| 11 | vocalization behavior (GO:0071625) | 4.40043257 |
| 12 | protein localization to synapse (GO:0035418) | 4.32315935 |
| 13 | dendritic spine morphogenesis (GO:0060997) | 4.30662691 |
| 14 | behavioral response to nicotine (GO:0035095) | 4.25662429 |
| 15 | establishment of mitochondrion localization (GO:0051654) | 4.24934631 |
| 16 | layer formation in cerebral cortex (GO:0021819) | 4.12701043 |
| 17 | glutamate secretion (GO:0014047) | 4.12477373 |
| 18 | neuron recognition (GO:0008038) | 4.11328784 |
| 19 | locomotory exploration behavior (GO:0035641) | 4.07921164 |
| 20 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.06513340 |
| 21 | presynaptic membrane organization (GO:0097090) | 4.05252038 |
| 22 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.98694203 |
| 23 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.89637976 |
| 24 | neurofilament cytoskeleton organization (GO:0060052) | 3.87696285 |
| 25 | neuronal action potential propagation (GO:0019227) | 3.86574014 |
| 26 | presynaptic membrane assembly (GO:0097105) | 3.86489870 |
| 27 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.81913188 |
| 28 | fatty acid elongation (GO:0030497) | 3.75617195 |
| 29 | myelination (GO:0042552) | 3.73009991 |
| 30 | ensheathment of neurons (GO:0007272) | 3.70156192 |
| 31 | axon ensheathment (GO:0008366) | 3.70156192 |
| 32 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.65767080 |
| 33 | axonal fasciculation (GO:0007413) | 3.61762619 |
| 34 | negative regulation of neurotransmitter transport (GO:0051589) | 3.56910210 |
| 35 | glutamate receptor signaling pathway (GO:0007215) | 3.51947266 |
| 36 | dendrite morphogenesis (GO:0048813) | 3.48498876 |
| 37 | transmission of nerve impulse (GO:0019226) | 3.48134504 |
| 38 | regulation of synaptic vesicle transport (GO:1902803) | 3.47487348 |
| 39 | adult walking behavior (GO:0007628) | 3.46234270 |
| 40 | exploration behavior (GO:0035640) | 3.45631979 |
| 41 | regulation of synapse structural plasticity (GO:0051823) | 3.45630231 |
| 42 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.45575742 |
| 43 | gamma-aminobutyric acid transport (GO:0015812) | 3.45243540 |
| 44 | synaptic transmission, glutamatergic (GO:0035249) | 3.44842432 |
| 45 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.42262828 |
| 46 | L-amino acid import (GO:0043092) | 3.39066420 |
| 47 | neuromuscular synaptic transmission (GO:0007274) | 3.38192618 |
| 48 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.35322567 |
| 49 | glycine transport (GO:0015816) | 3.34684170 |
| 50 | neuron-neuron synaptic transmission (GO:0007270) | 3.34045769 |
| 51 | postsynaptic membrane organization (GO:0001941) | 3.28210991 |
| 52 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.26608849 |
| 53 | neurotransmitter secretion (GO:0007269) | 3.24093871 |
| 54 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.22286482 |
| 55 | regulation of neurotransmitter levels (GO:0001505) | 3.21975629 |
| 56 | auditory behavior (GO:0031223) | 3.21914171 |
| 57 | membrane depolarization during action potential (GO:0086010) | 3.18349451 |
| 58 | negative regulation of axonogenesis (GO:0050771) | 3.17004451 |
| 59 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.15513418 |
| 60 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.15404081 |
| 61 | negative regulation of microtubule polymerization (GO:0031115) | 3.14559808 |
| 62 | neuronal ion channel clustering (GO:0045161) | 3.14401350 |
| 63 | positive regulation of synapse maturation (GO:0090129) | 3.14065529 |
| 64 | axon extension (GO:0048675) | 3.12856257 |
| 65 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.12270339 |
| 66 | cell migration in hindbrain (GO:0021535) | 3.11318655 |
| 67 | positive regulation of membrane potential (GO:0045838) | 3.10768724 |
| 68 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.10588800 |
| 69 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.09772245 |
| 70 | synapse organization (GO:0050808) | 3.09546133 |
| 71 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.09200119 |
| 72 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.08279942 |
| 73 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.07910357 |
| 74 | cerebellar granule cell differentiation (GO:0021707) | 3.07094275 |
| 75 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.06499135 |
| 76 | mitochondrion transport along microtubule (GO:0047497) | 3.04335314 |
| 77 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.04335314 |
| 78 | synaptic vesicle endocytosis (GO:0048488) | 3.04020090 |
| 79 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.04006256 |
| 80 | long-term memory (GO:0007616) | 3.03734698 |
| 81 | cellular potassium ion homeostasis (GO:0030007) | 3.03665370 |
| 82 | membrane depolarization (GO:0051899) | 3.00555304 |
| 83 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.99977024 |
| 84 | negative regulation of protein localization to cell surface (GO:2000009) | 2.96857755 |
| 85 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.96646032 |
| 86 | neurotransmitter transport (GO:0006836) | 2.95621842 |
| 87 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.94995017 |
| 88 | short-term memory (GO:0007614) | 2.94770727 |
| 89 | mechanosensory behavior (GO:0007638) | 2.94709657 |
| 90 | regulation of postsynaptic membrane potential (GO:0060078) | 2.94508392 |
| 91 | regulation of dendritic spine development (GO:0060998) | 2.93658914 |
| 92 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.92753670 |
| 93 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.92131952 |
| 94 | regulation of neurotransmitter transport (GO:0051588) | 2.91886633 |
| 95 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.91545134 |
| 96 | startle response (GO:0001964) | 2.91230206 |
| 97 | dendritic spine organization (GO:0097061) | 2.89877443 |
| 98 | regulation of synaptic plasticity (GO:0048167) | 2.89623880 |
| 99 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.89479758 |
| 100 | organelle transport along microtubule (GO:0072384) | 2.86779565 |
| 101 | neuromuscular process controlling balance (GO:0050885) | 2.84374214 |
| 102 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.83658200 |
| 103 | positive regulation of dendritic spine development (GO:0060999) | 2.82603471 |
| 104 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.81837764 |
| 105 | response to auditory stimulus (GO:0010996) | 2.81035702 |
| 106 | behavioral fear response (GO:0001662) | 2.80648286 |
| 107 | behavioral defense response (GO:0002209) | 2.80648286 |
| 108 | regulation of neurotransmitter secretion (GO:0046928) | 2.79832336 |
| 109 | axon cargo transport (GO:0008088) | 2.79497592 |
| 110 | synapse assembly (GO:0007416) | 2.78183535 |
| 111 | regulation of collateral sprouting (GO:0048670) | 2.76867315 |
| 112 | neuron remodeling (GO:0016322) | 2.76866015 |
| 113 | adult behavior (GO:0030534) | 2.76433712 |
| 114 | neurotransmitter uptake (GO:0001504) | 2.76230653 |
| 115 | dendrite development (GO:0016358) | 2.74946507 |
| 116 | mating behavior (GO:0007617) | 2.74685642 |
| 117 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.74272691 |
| 118 | nerve growth factor signaling pathway (GO:0038180) | 2.73446389 |
| 119 | apical protein localization (GO:0045176) | 2.73228637 |
| 120 | membrane hyperpolarization (GO:0060081) | 2.73185316 |
| 121 | negative regulation of axon extension (GO:0030517) | 2.72820238 |
| 122 | long-term synaptic potentiation (GO:0060291) | 2.72446825 |
| 123 | learning (GO:0007612) | 2.71742467 |
| 124 | positive regulation of synapse assembly (GO:0051965) | 2.71183186 |
| 125 | oligodendrocyte differentiation (GO:0048709) | 2.70972260 |
| 126 | response to methylmercury (GO:0051597) | 2.70624552 |
| 127 | regulation of vesicle fusion (GO:0031338) | 2.70379280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.34575267 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.47661421 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.08440473 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.02523780 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.94061687 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.67856937 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.67856937 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.67056076 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.55787678 |
| 10 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.50009749 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.49955405 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.49514433 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.49444167 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.48975303 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.42303680 |
| 16 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.37476664 |
| 17 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.36731510 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.29356101 |
| 19 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.22319762 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.21363522 |
| 21 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.18002914 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.15791752 |
| 23 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.00182662 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.99964247 |
| 25 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.91470058 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.90565824 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.84443717 |
| 28 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.79678009 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.76930693 |
| 30 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.76051216 |
| 31 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.75081371 |
| 32 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.74539973 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.70188626 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.68443171 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.64144421 |
| 36 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.57124119 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.57069307 |
| 38 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.56146040 |
| 39 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.54372984 |
| 40 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.53294901 |
| 41 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.45274391 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40277747 |
| 43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.39641889 |
| 44 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39425508 |
| 45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.38705982 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38235307 |
| 47 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37786307 |
| 48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.35205262 |
| 49 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.33700362 |
| 50 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.31646450 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30827441 |
| 52 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.30691351 |
| 53 | P300_19829295_ChIP-Seq_ESCs_Human | 1.29072973 |
| 54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23162863 |
| 55 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.21260756 |
| 56 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.20157620 |
| 57 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.19816611 |
| 58 | VDR_22108803_ChIP-Seq_LS180_Human | 1.19654746 |
| 59 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.19551934 |
| 60 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16761417 |
| 61 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16288252 |
| 62 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.16196418 |
| 63 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.16187759 |
| 64 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14586388 |
| 65 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.13187054 |
| 66 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12518748 |
| 67 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12020043 |
| 68 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11075662 |
| 69 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.08896679 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.07892057 |
| 71 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07886474 |
| 72 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.07323848 |
| 73 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.06965543 |
| 74 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05781253 |
| 75 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.05744026 |
| 76 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.04113823 |
| 77 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.03900252 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01080802 |
| 79 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00019935 |
| 80 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99956000 |
| 81 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99799545 |
| 82 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99783503 |
| 83 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99320843 |
| 84 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99045389 |
| 85 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98094707 |
| 86 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.97816895 |
| 87 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97433097 |
| 88 | FUS_26573619_Chip-Seq_HEK293_Human | 0.95057449 |
| 89 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94957480 |
| 90 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.94740796 |
| 91 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.94297275 |
| 92 | AR_19668381_ChIP-Seq_PC3_Human | 0.94022623 |
| 93 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.93943047 |
| 94 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93454847 |
| 95 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92233029 |
| 96 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92069612 |
| 97 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.91968127 |
| 98 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90689058 |
| 99 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.89989352 |
| 100 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88782052 |
| 101 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.87447641 |
| 102 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.86470948 |
| 103 | KDM2B_26808549_Chip-Seq_K562_Human | 0.86245977 |
| 104 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86166361 |
| 105 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85936220 |
| 106 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.85452487 |
| 107 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85452487 |
| 108 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.84347423 |
| 109 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.83669454 |
| 110 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.83244259 |
| 111 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.83195082 |
| 112 | JUN_21703547_ChIP-Seq_K562_Human | 0.82288584 |
| 113 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.82255800 |
| 114 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81968527 |
| 115 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.81764989 |
| 116 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.79184049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.31335968 |
| 2 | MP0003880_abnormal_central_pattern | 4.99333065 |
| 3 | MP0004270_analgesia | 4.09022426 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.61387471 |
| 5 | MP0005423_abnormal_somatic_nervous | 3.22315767 |
| 6 | MP0009745_abnormal_behavioral_response | 3.01198923 |
| 7 | MP0002064_seizures | 2.99772821 |
| 8 | MP0002063_abnormal_learning/memory/cond | 2.97349776 |
| 9 | MP0001486_abnormal_startle_reflex | 2.79768115 |
| 10 | MP0000920_abnormal_myelination | 2.77533653 |
| 11 | MP0002272_abnormal_nervous_system | 2.69581303 |
| 12 | MP0009046_muscle_twitch | 2.63309219 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.61763716 |
| 14 | MP0000778_abnormal_nervous_system | 2.58478555 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.53467697 |
| 16 | MP0003329_amyloid_beta_deposits | 2.50379446 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.36667985 |
| 18 | MP0001529_abnormal_vocalization | 2.25040562 |
| 19 | MP0004885_abnormal_endolymph | 2.11313079 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.08551471 |
| 21 | MP0002822_catalepsy | 1.99801197 |
| 22 | MP0002733_abnormal_thermal_nociception | 1.99486254 |
| 23 | MP0001970_abnormal_pain_threshold | 1.95943187 |
| 24 | MP0003121_genomic_imprinting | 1.93618746 |
| 25 | MP0001905_abnormal_dopamine_level | 1.90993935 |
| 26 | MP0004142_abnormal_muscle_tone | 1.86947619 |
| 27 | MP0002735_abnormal_chemical_nociception | 1.83441221 |
| 28 | MP0000955_abnormal_spinal_cord | 1.81973436 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.78557003 |
| 30 | MP0002736_abnormal_nociception_after | 1.77754749 |
| 31 | MP0002184_abnormal_innervation | 1.77152254 |
| 32 | MP0008569_lethality_at_weaning | 1.76509543 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.74745702 |
| 34 | MP0004924_abnormal_behavior | 1.74745702 |
| 35 | MP0004742_abnormal_vestibular_system | 1.74592135 |
| 36 | MP0003690_abnormal_glial_cell | 1.66660894 |
| 37 | MP0001501_abnormal_sleep_pattern | 1.64720287 |
| 38 | MP0002882_abnormal_neuron_morphology | 1.63458775 |
| 39 | MP0004811_abnormal_neuron_physiology | 1.62846748 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.61156224 |
| 41 | MP0003634_abnormal_glial_cell | 1.58965543 |
| 42 | MP0006276_abnormal_autonomic_nervous | 1.58261192 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.53476052 |
| 44 | MP0009780_abnormal_chondrocyte_physiolo | 1.44826863 |
| 45 | MP0002638_abnormal_pupillary_reflex | 1.44563064 |
| 46 | MP0003633_abnormal_nervous_system | 1.41181622 |
| 47 | MP0002229_neurodegeneration | 1.40436968 |
| 48 | MP0003631_nervous_system_phenotype | 1.37946132 |
| 49 | MP0004858_abnormal_nervous_system | 1.33643983 |
| 50 | MP0005409_darkened_coat_color | 1.32417958 |
| 51 | MP0003632_abnormal_nervous_system | 1.28820054 |
| 52 | MP0005171_absent_coat_pigmentation | 1.26104567 |
| 53 | MP0001485_abnormal_pinna_reflex | 1.25537248 |
| 54 | MP0003123_paternal_imprinting | 1.23438481 |
| 55 | MP0008877_abnormal_DNA_methylation | 1.23165759 |
| 56 | MP0002152_abnormal_brain_morphology | 1.23005386 |
| 57 | MP0005645_abnormal_hypothalamus_physiol | 1.22895912 |
| 58 | MP0001984_abnormal_olfaction | 1.20095567 |
| 59 | MP0001502_abnormal_circadian_rhythm | 1.18748100 |
| 60 | MP0000604_amyloidosis | 1.17851036 |
| 61 | MP0005646_abnormal_pituitary_gland | 1.16260884 |
| 62 | MP0004133_heterotaxia | 1.06444576 |
| 63 | MP0002752_abnormal_somatic_nervous | 1.06324286 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 1.06037270 |
| 65 | MP0002653_abnormal_ependyma_morphology | 1.04965309 |
| 66 | MP0001963_abnormal_hearing_physiology | 1.03188702 |
| 67 | MP0003890_abnormal_embryonic-extraembry | 0.98229799 |
| 68 | MP0003122_maternal_imprinting | 0.96557639 |
| 69 | MP0004043_abnormal_pH_regulation | 0.95514354 |
| 70 | MP0003879_abnormal_hair_cell | 0.94934618 |
| 71 | MP0000569_abnormal_digit_pigmentation | 0.94656278 |
| 72 | MP0001188_hyperpigmentation | 0.93763859 |
| 73 | MP0000751_myopathy | 0.92288408 |
| 74 | MP0001177_atelectasis | 0.91463778 |
| 75 | MP0004145_abnormal_muscle_electrophysio | 0.90052899 |
| 76 | MP0005410_abnormal_fertilization | 0.89032144 |
| 77 | MP0000631_abnormal_neuroendocrine_gland | 0.88844705 |
| 78 | MP0003136_yellow_coat_color | 0.87518526 |
| 79 | MP0005623_abnormal_meninges_morphology | 0.87244135 |
| 80 | MP0002069_abnormal_eating/drinking_beha | 0.85041176 |
| 81 | MP0002909_abnormal_adrenal_gland | 0.84653945 |
| 82 | MP0000566_synostosis | 0.82219690 |
| 83 | MP0001348_abnormal_lacrimal_gland | 0.80769094 |
| 84 | MP0002751_abnormal_autonomic_nervous | 0.80749270 |
| 85 | MP0003950_abnormal_plasma_membrane | 0.80708648 |
| 86 | MP0010386_abnormal_urinary_bladder | 0.78441187 |
| 87 | MP0003861_abnormal_nervous_system | 0.76348447 |
| 88 | MP0001986_abnormal_taste_sensitivity | 0.75861014 |
| 89 | MP0003787_abnormal_imprinting | 0.75617639 |
| 90 | MP0001299_abnormal_eye_distance/ | 0.75243316 |
| 91 | MP0003137_abnormal_impulse_conducting | 0.73734338 |
| 92 | MP0005253_abnormal_eye_physiology | 0.73134784 |
| 93 | MP0003938_abnormal_ear_development | 0.72037420 |
| 94 | MP0008789_abnormal_olfactory_epithelium | 0.71963861 |
| 95 | MP0003011_delayed_dark_adaptation | 0.71202525 |
| 96 | MP0004085_abnormal_heartbeat | 0.70495027 |
| 97 | MP0000026_abnormal_inner_ear | 0.69830214 |
| 98 | MP0000747_muscle_weakness | 0.69541488 |
| 99 | MP0008874_decreased_physiological_sensi | 0.65352021 |
| 100 | MP0006072_abnormal_retinal_apoptosis | 0.65204796 |
| 101 | MP0005499_abnormal_olfactory_system | 0.63546833 |
| 102 | MP0005394_taste/olfaction_phenotype | 0.63546833 |
| 103 | MP0000462_abnormal_digestive_system | 0.62348989 |
| 104 | MP0001943_abnormal_respiration | 0.61872299 |
| 105 | MP0005187_abnormal_penis_morphology | 0.61438611 |
| 106 | MP0002102_abnormal_ear_morphology | 0.60718497 |
| 107 | MP0005195_abnormal_posterior_eye | 0.60464887 |
| 108 | MP0008872_abnormal_physiological_respon | 0.59226648 |
| 109 | MP0002090_abnormal_vision | 0.58881802 |
| 110 | MP0008995_early_reproductive_senescence | 0.57785794 |
| 111 | MP0008260_abnormal_autophagy | 0.57512829 |
| 112 | MP0001664_abnormal_digestion | 0.57322188 |
| 113 | MP0002876_abnormal_thyroid_physiology | 0.57303408 |
| 114 | MP0003075_altered_response_to | 0.57260487 |
| 115 | MP0004130_abnormal_muscle_cell | 0.57226790 |
| 116 | MP0004147_increased_porphyrin_level | 0.55653726 |
| 117 | MP0006292_abnormal_olfactory_placode | 0.55367906 |
| 118 | MP0010768_mortality/aging | 0.55207607 |
| 119 | MP0000534_abnormal_ureter_morphology | 0.54828728 |
| 120 | MP0005535_abnormal_body_temperature | 0.54529988 |
| 121 | MP0010769_abnormal_survival | 0.54052947 |
| 122 | MP0002082_postnatal_lethality | 0.53692274 |
| 123 | MP0010770_preweaning_lethality | 0.53692274 |
| 124 | MP0004134_abnormal_chest_morphology | 0.53580151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.08474733 |
| 2 | Neurofibrillary tangles (HP:0002185) | 5.21633181 |
| 3 | Focal motor seizures (HP:0011153) | 5.09789739 |
| 4 | Supranuclear gaze palsy (HP:0000605) | 4.63533359 |
| 5 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.54845837 |
| 6 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.54845837 |
| 7 | Abnormality of the corticospinal tract (HP:0002492) | 4.52262131 |
| 8 | Cerebral inclusion bodies (HP:0100314) | 4.30614757 |
| 9 | Ankle clonus (HP:0011448) | 4.27336478 |
| 10 | Focal seizures (HP:0007359) | 4.16829411 |
| 11 | Spastic gait (HP:0002064) | 3.69681860 |
| 12 | Epileptic encephalopathy (HP:0200134) | 3.68417714 |
| 13 | Termporal pattern (HP:0011008) | 3.62963389 |
| 14 | Insidious onset (HP:0003587) | 3.62963389 |
| 15 | Peripheral hypomyelination (HP:0007182) | 3.46636193 |
| 16 | Visual hallucinations (HP:0002367) | 3.42855739 |
| 17 | Dysmetria (HP:0001310) | 3.38981021 |
| 18 | Limb dystonia (HP:0002451) | 3.38756062 |
| 19 | Broad-based gait (HP:0002136) | 3.24414518 |
| 20 | Mutism (HP:0002300) | 3.19461341 |
| 21 | Action tremor (HP:0002345) | 3.17830802 |
| 22 | Cortical dysplasia (HP:0002539) | 3.10589627 |
| 23 | Progressive cerebellar ataxia (HP:0002073) | 3.09514212 |
| 24 | Intention tremor (HP:0002080) | 3.02287173 |
| 25 | Failure to thrive in infancy (HP:0001531) | 3.01645922 |
| 26 | Cerebral hypomyelination (HP:0006808) | 2.98792915 |
| 27 | Urinary urgency (HP:0000012) | 2.98218030 |
| 28 | Atonic seizures (HP:0010819) | 2.97318133 |
| 29 | Onion bulb formation (HP:0003383) | 2.89727483 |
| 30 | Scanning speech (HP:0002168) | 2.89292138 |
| 31 | Megalencephaly (HP:0001355) | 2.89248027 |
| 32 | Agitation (HP:0000713) | 2.82120258 |
| 33 | Abnormality of the labia minora (HP:0012880) | 2.80827497 |
| 34 | Akinesia (HP:0002304) | 2.79446465 |
| 35 | Dialeptic seizures (HP:0011146) | 2.71239384 |
| 36 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.67503771 |
| 37 | Lower limb muscle weakness (HP:0007340) | 2.66998427 |
| 38 | Absence seizures (HP:0002121) | 2.65243820 |
| 39 | Hyperventilation (HP:0002883) | 2.64341545 |
| 40 | Pheochromocytoma (HP:0002666) | 2.61804657 |
| 41 | Abnormal eating behavior (HP:0100738) | 2.60511801 |
| 42 | Lissencephaly (HP:0001339) | 2.59495140 |
| 43 | Generalized tonic-clonic seizures (HP:0002069) | 2.59466657 |
| 44 | Retinal dysplasia (HP:0007973) | 2.59151189 |
| 45 | Drooling (HP:0002307) | 2.57569498 |
| 46 | Excessive salivation (HP:0003781) | 2.57569498 |
| 47 | Sensory axonal neuropathy (HP:0003390) | 2.57416241 |
| 48 | Pachygyria (HP:0001302) | 2.57065107 |
| 49 | Anxiety (HP:0000739) | 2.54693737 |
| 50 | Poor eye contact (HP:0000817) | 2.54377347 |
| 51 | Spastic tetraplegia (HP:0002510) | 2.53330515 |
| 52 | Torticollis (HP:0000473) | 2.52958856 |
| 53 | Progressive inability to walk (HP:0002505) | 2.48895206 |
| 54 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.48738795 |
| 55 | Abnormality of the lower motor neuron (HP:0002366) | 2.48139247 |
| 56 | Poor suck (HP:0002033) | 2.46357967 |
| 57 | Dysdiadochokinesis (HP:0002075) | 2.45167557 |
| 58 | Ulnar claw (HP:0001178) | 2.40485543 |
| 59 | Polyphagia (HP:0002591) | 2.37658346 |
| 60 | Truncal ataxia (HP:0002078) | 2.35065177 |
| 61 | Hemiparesis (HP:0001269) | 2.34892966 |
| 62 | Depression (HP:0000716) | 2.34695338 |
| 63 | Clonus (HP:0002169) | 2.31595060 |
| 64 | Alacrima (HP:0000522) | 2.30837254 |
| 65 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.29563236 |
| 66 | Focal dystonia (HP:0004373) | 2.29550421 |
| 67 | Status epilepticus (HP:0002133) | 2.28557476 |
| 68 | Abnormality of binocular vision (HP:0011514) | 2.25438633 |
| 69 | Diplopia (HP:0000651) | 2.25438633 |
| 70 | Febrile seizures (HP:0002373) | 2.24092352 |
| 71 | Neuroendocrine neoplasm (HP:0100634) | 2.22401217 |
| 72 | Hypoplasia of the corpus callosum (HP:0002079) | 2.21542380 |
| 73 | Fetal akinesia sequence (HP:0001989) | 2.21463205 |
| 74 | Postural instability (HP:0002172) | 2.21310651 |
| 75 | Gaze-evoked nystagmus (HP:0000640) | 2.20803734 |
| 76 | Genetic anticipation (HP:0003743) | 2.20700733 |
| 77 | Abnormal social behavior (HP:0012433) | 2.19813466 |
| 78 | Impaired social interactions (HP:0000735) | 2.19813466 |
| 79 | Amyotrophic lateral sclerosis (HP:0007354) | 2.18475653 |
| 80 | Parakeratosis (HP:0001036) | 2.16683375 |
| 81 | Amblyopia (HP:0000646) | 2.15789938 |
| 82 | Craniofacial dystonia (HP:0012179) | 2.15450016 |
| 83 | Esotropia (HP:0000565) | 2.15276771 |
| 84 | Generalized myoclonic seizures (HP:0002123) | 2.13904628 |
| 85 | Thickened helices (HP:0000391) | 2.12458974 |
| 86 | Nephrogenic diabetes insipidus (HP:0009806) | 2.10783720 |
| 87 | Abnormal auditory evoked potentials (HP:0006958) | 2.10205725 |
| 88 | Neuronal loss in central nervous system (HP:0002529) | 2.09627506 |
| 89 | Leukodystrophy (HP:0002415) | 2.07682040 |
| 90 | CNS hypomyelination (HP:0003429) | 2.06193235 |
| 91 | Slow saccadic eye movements (HP:0000514) | 2.05537728 |
| 92 | Congenital primary aphakia (HP:0007707) | 2.04980530 |
| 93 | Spastic tetraparesis (HP:0001285) | 2.04351466 |
| 94 | Epileptiform EEG discharges (HP:0011182) | 2.04165716 |
| 95 | Medial flaring of the eyebrow (HP:0010747) | 2.03473117 |
| 96 | EEG with generalized epileptiform discharges (HP:0011198) | 2.00091221 |
| 97 | Papilledema (HP:0001085) | 1.99752051 |
| 98 | Aplasia involving bones of the extremities (HP:0009825) | 1.99098107 |
| 99 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.99098107 |
| 100 | Aplasia of the phalanges of the hand (HP:0009802) | 1.99098107 |
| 101 | Clumsiness (HP:0002312) | 1.98545095 |
| 102 | Specific learning disability (HP:0001328) | 1.97569411 |
| 103 | Hypsarrhythmia (HP:0002521) | 1.97088189 |
| 104 | Hemiplegia (HP:0002301) | 1.96776863 |
| 105 | Hypoplasia of the brainstem (HP:0002365) | 1.96425834 |
| 106 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.96425834 |
| 107 | Absent speech (HP:0001344) | 1.94338372 |
| 108 | Poor speech (HP:0002465) | 1.93274761 |
| 109 | Blue irides (HP:0000635) | 1.92670963 |
| 110 | Delusions (HP:0000746) | 1.92352055 |
| 111 | Oligomenorrhea (HP:0000876) | 1.90330394 |
| 112 | Sleep apnea (HP:0010535) | 1.90228989 |
| 113 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.88415937 |
| 114 | Hammertoe (HP:0001765) | 1.86474595 |
| 115 | Gait imbalance (HP:0002141) | 1.85894231 |
| 116 | Incomplete penetrance (HP:0003829) | 1.85075798 |
| 117 | Bowel incontinence (HP:0002607) | 1.84373277 |
| 118 | Abnormality of salivation (HP:0100755) | 1.84075714 |
| 119 | Vaginal atresia (HP:0000148) | 1.82347802 |
| 120 | Stereotypic behavior (HP:0000733) | 1.81753705 |
| 121 | Inability to walk (HP:0002540) | 1.81697999 |
| 122 | Muscular hypotonia of the trunk (HP:0008936) | 1.81389764 |
| 123 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.81313733 |
| 124 | Abnormal hair whorl (HP:0010721) | 1.80243840 |
| 125 | Genital tract atresia (HP:0001827) | 1.80112964 |
| 126 | Paraplegia (HP:0010550) | 1.79818897 |
| 127 | Impaired vibratory sensation (HP:0002495) | 1.73222692 |
| 128 | Hypoventilation (HP:0002791) | 1.71990451 |
| 129 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.71479137 |
| 130 | Abnormality of alanine metabolism (HP:0010916) | 1.71479137 |
| 131 | Hyperalaninemia (HP:0003348) | 1.71479137 |
| 132 | Polymicrogyria (HP:0002126) | 1.71235242 |
| 133 | Myotonia (HP:0002486) | 1.70840660 |
| 134 | Intellectual disability, severe (HP:0010864) | 1.70540753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.40618304 |
| 2 | EPHA4 | 3.03277813 |
| 3 | STK39 | 2.83751088 |
| 4 | MAP3K9 | 2.80772131 |
| 5 | NTRK3 | 2.76454673 |
| 6 | OXSR1 | 2.58316397 |
| 7 | CASK | 2.35110729 |
| 8 | CDK19 | 2.23574506 |
| 9 | PAK6 | 2.15716196 |
| 10 | UHMK1 | 2.03704223 |
| 11 | NTRK2 | 2.03446972 |
| 12 | PKN1 | 2.01163227 |
| 13 | MINK1 | 1.99536015 |
| 14 | PNCK | 1.98289356 |
| 15 | MAP3K4 | 1.96676367 |
| 16 | DAPK2 | 1.79262923 |
| 17 | NTRK1 | 1.75707032 |
| 18 | BCR | 1.69425980 |
| 19 | MAP2K7 | 1.67563155 |
| 20 | DYRK2 | 1.60221954 |
| 21 | MAPK13 | 1.58260686 |
| 22 | PHKG2 | 1.56483070 |
| 23 | PHKG1 | 1.56483070 |
| 24 | LIMK1 | 1.54596060 |
| 25 | CDK5 | 1.54016128 |
| 26 | TNIK | 1.51753542 |
| 27 | FGFR2 | 1.50088375 |
| 28 | KSR2 | 1.43034743 |
| 29 | CSNK1G2 | 1.42117557 |
| 30 | CAMK2B | 1.40652982 |
| 31 | MAPKAPK5 | 1.40574725 |
| 32 | PRPF4B | 1.36559598 |
| 33 | CSNK1G3 | 1.30241725 |
| 34 | TYRO3 | 1.28605909 |
| 35 | PRKD3 | 1.22875821 |
| 36 | SGK494 | 1.21074652 |
| 37 | SGK223 | 1.21074652 |
| 38 | CSNK1A1L | 1.16804242 |
| 39 | MARK2 | 1.15267986 |
| 40 | TRIM28 | 1.14806351 |
| 41 | CDK14 | 1.13842458 |
| 42 | CDK15 | 1.11039284 |
| 43 | CDK18 | 1.10412840 |
| 44 | KSR1 | 1.10085433 |
| 45 | PLK2 | 1.09572724 |
| 46 | WNK4 | 1.07529385 |
| 47 | CAMK2A | 1.07393343 |
| 48 | EPHB1 | 1.06130101 |
| 49 | PAK3 | 1.01080667 |
| 50 | DYRK1B | 1.00073531 |
| 51 | CDK11A | 0.98738262 |
| 52 | FGR | 0.98237341 |
| 53 | MAP2K4 | 0.97885728 |
| 54 | EPHA3 | 0.97864931 |
| 55 | ROCK2 | 0.96161862 |
| 56 | SGK2 | 0.95066636 |
| 57 | GRK5 | 0.93023570 |
| 58 | ARAF | 0.92286180 |
| 59 | MAP4K2 | 0.90734225 |
| 60 | NEK6 | 0.89292381 |
| 61 | WNK1 | 0.89258746 |
| 62 | SIK2 | 0.88854425 |
| 63 | CAMK2D | 0.88715585 |
| 64 | CAMKK1 | 0.88198426 |
| 65 | PRKCG | 0.87014452 |
| 66 | CSNK1G1 | 0.85807756 |
| 67 | DYRK3 | 0.83364036 |
| 68 | TESK2 | 0.81836566 |
| 69 | EPHB2 | 0.80905486 |
| 70 | MAP3K12 | 0.80429003 |
| 71 | STK11 | 0.80332042 |
| 72 | MAP3K11 | 0.78923279 |
| 73 | DYRK1A | 0.77272672 |
| 74 | CAMK2G | 0.77255634 |
| 75 | ICK | 0.75787895 |
| 76 | MAP3K2 | 0.72824597 |
| 77 | PRKCE | 0.71749590 |
| 78 | ERBB3 | 0.69755276 |
| 79 | FES | 0.66732023 |
| 80 | DAPK3 | 0.64911415 |
| 81 | MET | 0.62673153 |
| 82 | FYN | 0.60865261 |
| 83 | PDPK1 | 0.57946128 |
| 84 | WNK3 | 0.57288345 |
| 85 | RPS6KA2 | 0.56641100 |
| 86 | PRKCZ | 0.56466978 |
| 87 | PRKCH | 0.56390805 |
| 88 | RIPK4 | 0.56249567 |
| 89 | RET | 0.55351035 |
| 90 | LATS2 | 0.53807387 |
| 91 | DAPK1 | 0.53745087 |
| 92 | CAMK1 | 0.53709489 |
| 93 | CAMK4 | 0.53420266 |
| 94 | MUSK | 0.52584719 |
| 95 | MAPK15 | 0.51821254 |
| 96 | PTK2B | 0.49130908 |
| 97 | SGK3 | 0.48854936 |
| 98 | CAMK1G | 0.48808070 |
| 99 | ADRBK2 | 0.46854840 |
| 100 | PRKD1 | 0.46632811 |
| 101 | SGK1 | 0.45964186 |
| 102 | CAMKK2 | 0.45943782 |
| 103 | PINK1 | 0.45842839 |
| 104 | PRKACA | 0.45557180 |
| 105 | CLK1 | 0.45274873 |
| 106 | CSNK1A1 | 0.44164657 |
| 107 | CSNK1E | 0.43393691 |
| 108 | PDK1 | 0.41661252 |
| 109 | ALK | 0.39909643 |
| 110 | PRKG1 | 0.39808216 |
| 111 | MAPK12 | 0.39644367 |
| 112 | NME1 | 0.39306746 |
| 113 | BMPR1B | 0.37753550 |
| 114 | PRKAA1 | 0.36566669 |
| 115 | RPS6KA4 | 0.36510525 |
| 116 | MAP3K13 | 0.36071103 |
| 117 | SIK3 | 0.35558047 |
| 118 | CSNK1D | 0.35122123 |
| 119 | ERBB2 | 0.34534910 |
| 120 | RPS6KA3 | 0.33662502 |
| 121 | PRKCQ | 0.33198118 |
| 122 | MAPK8 | 0.33085686 |
| 123 | MAPK10 | 0.31172756 |
| 124 | PRKCA | 0.30628986 |
| 125 | STK38 | 0.29609076 |
| 126 | MAPK9 | 0.28329794 |
| 127 | ADRBK1 | 0.27412727 |
| 128 | MAPK4 | 0.27281054 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.12104331 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.83538079 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.67333988 |
| 4 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.52507420 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.51745456 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.45410556 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.36393711 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.35322668 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.16203821 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.06781324 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.00738148 |
| 12 | Axon guidance_Homo sapiens_hsa04360 | 2.00560106 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 1.98996271 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.94543258 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.84177517 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.80343877 |
| 17 | Cocaine addiction_Homo sapiens_hsa05030 | 1.79061128 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.77340597 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.75291025 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.73124801 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.66073601 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.62455377 |
| 23 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.61037339 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.52415894 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.50063776 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 1.46463860 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.45645447 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.43488038 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.41890661 |
| 30 | Gap junction_Homo sapiens_hsa04540 | 1.41018133 |
| 31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.31793408 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.31764827 |
| 33 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.29234550 |
| 34 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.28826909 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.19092073 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.14620097 |
| 37 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13624918 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.11728075 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.11102456 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.11024525 |
| 41 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.10258427 |
| 42 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.08955798 |
| 43 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.05951232 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.04503518 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.03115951 |
| 46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.03092566 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 1.01850585 |
| 48 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.98492610 |
| 49 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.98158759 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 0.95058729 |
| 51 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.94927650 |
| 52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94086758 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91577743 |
| 54 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91425838 |
| 55 | Melanogenesis_Homo sapiens_hsa04916 | 0.90648640 |
| 56 | Parkinsons disease_Homo sapiens_hsa05012 | 0.89558891 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89059933 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.87359140 |
| 59 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.87264939 |
| 60 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.85800130 |
| 61 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.85685785 |
| 62 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.81178717 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80938743 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79757574 |
| 65 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.79082474 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78773804 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77814805 |
| 68 | Glioma_Homo sapiens_hsa05214 | 0.77144586 |
| 69 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.74885717 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.73312341 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72292939 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.69209296 |
| 73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68925957 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68664398 |
| 75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66751828 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.65958206 |
| 77 | Alcoholism_Homo sapiens_hsa05034 | 0.63508987 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.58664285 |
| 79 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.56383281 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53485527 |
| 81 | Tight junction_Homo sapiens_hsa04530 | 0.53253126 |
| 82 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.52268051 |
| 83 | Bile secretion_Homo sapiens_hsa04976 | 0.52117006 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51865482 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50083498 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49442571 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.49166371 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47638149 |
| 89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47296217 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.47095130 |
| 91 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44101743 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.43804173 |
| 93 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43252176 |
| 94 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.42787675 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.41560324 |
| 96 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.41466708 |
| 97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40875265 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.40671357 |
| 99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.40478161 |
| 100 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39210034 |
| 101 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37866319 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37601354 |
| 103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37520390 |
| 104 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35489929 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35021923 |
| 106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.34357057 |
| 107 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33876803 |
| 108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33409679 |
| 109 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.32991138 |
| 110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32271291 |
| 111 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31825595 |
| 112 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.31811718 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31562218 |
| 114 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29792217 |
| 115 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.29443502 |
| 116 | Histidine metabolism_Homo sapiens_hsa00340 | 0.29271123 |
| 117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.27178385 |

